Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Daptomycin therapy for osteomyelitis: a retrospective study.

Gallagher JC, Huntington JA, Culshaw D, McConnell SA, Yoon M, Berbari E.

BMC Infect Dis. 2012 Jun 12;12:133. doi: 10.1186/1471-2334-12-133.

PMID:
22691420
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Clinical experience with daptomycin for the treatment of patients with osteomyelitis.

Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R.

Am J Med. 2007 Oct;120(10 Suppl 1):S13-20.

PMID:
17904946
[PubMed - indexed for MEDLINE]
3.

Daptomycin use in neutropenic patients with documented gram-positive infections.

Rolston KV, Besece D, Lamp KC, Yoon M, McConnell SA, White P.

Support Care Cancer. 2014 Jan;22(1):7-14. doi: 10.1007/s00520-013-1947-8. Epub 2013 Aug 24.

PMID:
23975231
[PubMed - indexed for MEDLINE]
4.

Daptomycin experience in critical care patients: results from a registry.

Brown JE, Fominaya C, Christensen KJ, McConnell SA, Lamp KC.

Ann Pharmacother. 2012 Apr;46(4):495-502. doi: 10.1345/aph.1Q490. Epub 2012 Mar 27.

PMID:
22454446
[PubMed - indexed for MEDLINE]
5.

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients.

Lai CC, Sheng WH, Wang JT, Cheng A, Chuang YC, Chen YC, Chang SC.

BMC Infect Dis. 2013 Feb 4;13:66. doi: 10.1186/1471-2334-13-66.

PMID:
23379510
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.

Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

Pharmacotherapy. 2011 Jun;31(6):527-36. doi: 10.1592/phco.31.6.527.

PMID:
21923436
[PubMed - indexed for MEDLINE]
8.
9.

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.

Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.

Ann Pharmacother. 2009 Jul;43(7):1211-9. doi: 10.1345/aph.1M085. Epub 2009 Jul 7.

PMID:
19584384
[PubMed - indexed for MEDLINE]
10.

Clinical experience with daptomycin in Europe: the first 2.5 years.

Gonzalez-Ruiz A, Beiras-Fernandez A, Lehmkuhl H, Seaton RA, Loeffler J, Chaves RL.

J Antimicrob Chemother. 2011 Apr;66(4):912-9. doi: 10.1093/jac/dkq528. Epub 2011 Jan 25.

PMID:
21393205
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections.

Timerman A, Brites C, Bicudo E, Grinbaum RS, Costa Filho R, Carrilho CD, Bichels A, Barreto T.

Braz J Infect Dis. 2013 Nov-Dec;17(6):647-53. doi: 10.1016/j.bjid.2013.03.005. Epub 2013 Jul 31.

PMID:
23916455
[PubMed - indexed for MEDLINE]
Free Article
12.

Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry.

Crompton JA, North DS, McConnell SA, Lamp KC.

J Chemother. 2009 Aug;21(4):414-20.

PMID:
19622460
[PubMed - indexed for MEDLINE]
13.

Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.

Moenster RP, Linneman TW, Finnegan PM, McDonald JR.

Clin Ther. 2012 Jul;34(7):1521-7. doi: 10.1016/j.clinthera.2012.06.013. Epub 2012 Jun 29.

PMID:
22748973
[PubMed - indexed for MEDLINE]
14.

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database.

Seaton RA, Malizos KN, Viale P, Gargalianos-Kakolyris P, Santantonio T, Petrelli E, Pathan R, Heep M, Chaves RL.

J Antimicrob Chemother. 2013 Jul;68(7):1642-9. doi: 10.1093/jac/dkt067. Epub 2013 Mar 20.

PMID:
23515247
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.

Forrest GN, Donovan BJ, Lamp KC, Friedrich LV.

Ann Pharmacother. 2008 Feb;42(2):213-7. doi: 10.1345/aph.1K535. Epub 2008 Jan 22.

PMID:
18212253
[PubMed - indexed for MEDLINE]
16.

Clinical experience with daptomycin treatment of foot or ankle osteomyelitis: a preliminary study.

Holtom PD, Zalavras CG, Lamp KC, Park N, Friedrich LV.

Clin Orthop Relat Res. 2007 Aug;461:35-9.

PMID:
17549028
[PubMed - indexed for MEDLINE]
17.

Daptomycin for the treatment of surgical site infections.

Chamberlain RS, Culshaw DL, Donovan BJ, Lamp KC.

Surgery. 2009 Aug;146(2):316-24. doi: 10.1016/j.surg.2009.03.037.

PMID:
19628091
[PubMed - indexed for MEDLINE]
18.

Daptomycin use in patients with cancer and neutropenia: data from a retrospective registry.

Rolston KV, McConnell SA, Brown J, Lamp KC.

Clin Adv Hematol Oncol. 2010 Apr;8(4):249-56, 90.

PMID:
20505648
[PubMed - indexed for MEDLINE]
19.

Daptomycin in bone and joint infections: a review of the literature.

Rice DA, Mendez-Vigo L.

Arch Orthop Trauma Surg. 2009 Nov;129(11):1495-504. doi: 10.1007/s00402-008-0772-x. Epub 2008 Nov 7. Review.

PMID:
18989686
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Safety of daptomycin in patients completing more than 14 days of therapy: results from the CubicinĀ® Outcomes Registry and experience.

Rege S, Mohr J, Lamp KC, Yoon M, Lindfield KC.

Int J Antimicrob Agents. 2013 May;41(5):421-5. doi: 10.1016/j.ijantimicag.2012.12.008. Epub 2013 Feb 5.

PMID:
23394685
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk